Stakeholder Concurrence for Risk Treatment
Stakeholder Concurrence for Risk Treatment is a critical component within the Governance, Risk, and Compliance (GRC) framework that ensures all relevant parties agree upon and support the chosen approach for managing identified risks. In the context of system compliance, this process involves obtai… Stakeholder Concurrence for Risk Treatment is a critical component within the Governance, Risk, and Compliance (GRC) framework that ensures all relevant parties agree upon and support the chosen approach for managing identified risks. In the context of system compliance, this process involves obtaining formal agreement from key stakeholders—including business owners, IT management, security teams, compliance officers, and executive leadership—on how specific risks will be addressed. When an organization identifies risks through its risk assessment process, it must determine an appropriate risk treatment strategy. These strategies typically include risk mitigation (implementing controls to reduce risk), risk acceptance (acknowledging and tolerating the risk), risk transfer (shifting risk to a third party, such as through insurance), or risk avoidance (eliminating the activity causing the risk). Stakeholder concurrence ensures that the selected treatment aligns with organizational objectives, regulatory requirements, and resource availability. The concurrence process typically involves presenting risk findings, proposed treatment plans, residual risk levels, and associated costs to stakeholders for review and approval. This documentation creates an audit trail demonstrating due diligence and accountability. Stakeholders must understand the implications of each treatment option, including the potential impact on operations, compliance posture, and the organization's overall risk profile. A key aspect of stakeholder concurrence is the formal acceptance of residual risk—the risk that remains after treatment measures are applied. Authorizing officials or system owners must explicitly acknowledge and accept this residual risk, often through signed documentation or formal risk acceptance statements. This process is particularly important in frameworks such as NIST RMF, ISO 27005, and COBIT, where documented stakeholder agreement is a compliance requirement. Without proper concurrence, organizations may face audit findings, regulatory penalties, or misalignment between risk management activities and business objectives. Ultimately, stakeholder concurrence promotes transparency, shared responsibility, and informed decision-making in managing system-level risks across the enterprise.
Stakeholder Concurrence for Risk Treatment: A Comprehensive Guide for CGRC Exam Success
Introduction
Stakeholder concurrence for risk treatment is a critical concept within the Governance, Risk, and Compliance (GRC) domain, particularly relevant to the CGRC (Certified in Governance, Risk, and Compliance) certification exam. This guide provides an in-depth exploration of what stakeholder concurrence means, why it matters, how it works in practice, and how to approach exam questions on this topic.
What Is Stakeholder Concurrence for Risk Treatment?
Stakeholder concurrence for risk treatment refers to the formal process of obtaining agreement, acknowledgment, and approval from all relevant stakeholders regarding the chosen approach to managing identified risks within an information system or organization. In essence, it is the documented agreement among key parties that the selected risk treatment strategy — whether it involves risk acceptance, risk mitigation, risk avoidance, or risk transfer — is appropriate, justified, and aligned with organizational objectives.
Stakeholders in this context typically include:
• Authorizing Officials (AOs) — The senior officials who accept residual risk on behalf of the organization.
• System Owners — Individuals responsible for the operation and maintenance of the system.
• Information System Security Officers (ISSOs) — Personnel responsible for ensuring security controls are implemented and functioning.
• Chief Information Security Officers (CISOs) — Senior leaders overseeing the organization's cybersecurity posture.
• Mission/Business Owners — Stakeholders who depend on the system for achieving organizational missions.
• Risk Executive (Function) — The individual or group responsible for enterprise-wide risk management.
• Other Affected Parties — Including legal, privacy, compliance, and audit teams as applicable.
Why Is Stakeholder Concurrence Important?
Stakeholder concurrence for risk treatment is vital for several reasons:
1. Ensures Accountability and Transparency
When stakeholders formally agree on a risk treatment approach, there is a clear record of who approved what. This prevents finger-pointing if something goes wrong and establishes clear lines of accountability.
2. Aligns Risk Decisions with Business Objectives
Different stakeholders bring different perspectives. Business owners focus on mission impact, security personnel focus on threat mitigation, and legal teams focus on compliance. Concurrence ensures that risk treatment decisions balance all these perspectives and align with the organization's overall strategic goals.
3. Supports the Authorization Decision
In the Risk Management Framework (RMF), the Authorizing Official must make an informed decision about whether to authorize a system to operate. Stakeholder concurrence provides the AO with confidence that the risk treatment plan has been vetted by all relevant parties, making the authorization decision more defensible.
4. Reduces Residual Risk Blind Spots
When multiple stakeholders review and agree on risk treatments, the likelihood of overlooking a significant risk factor decreases. Each stakeholder brings domain expertise that contributes to a more comprehensive risk picture.
5. Fulfills Regulatory and Framework Requirements
Frameworks such as NIST SP 800-37 (Risk Management Framework) and NIST SP 800-39 (Managing Information Security Risk) explicitly require stakeholder involvement in risk decisions. Concurrence is not optional — it is a mandated step in the risk management process.
6. Facilitates Continuous Monitoring
When stakeholders have concurred on risk treatment, they are also implicitly agreeing to ongoing monitoring of those risks. This shared responsibility supports the continuous monitoring phase of the RMF.
How Stakeholder Concurrence Works in Practice
The process of obtaining stakeholder concurrence typically follows these steps:
Step 1: Risk Identification and Assessment
Before concurrence can be sought, risks must be identified, analyzed, and assessed. This involves conducting security assessments, vulnerability scans, and threat analyses to determine the nature and severity of risks to the system.
Step 2: Development of Risk Treatment Options
For each identified risk, treatment options are developed. These typically fall into four categories:
• Risk Mitigation — Implementing controls to reduce the likelihood or impact of the risk.
• Risk Acceptance — Formally acknowledging the risk and choosing to operate with it.
• Risk Avoidance — Eliminating the risk by removing the source or discontinuing the activity.
• Risk Transfer — Shifting the risk to a third party (e.g., through insurance or outsourcing).
Step 3: Documentation of the Risk Treatment Plan
The chosen treatment for each risk is documented in a Plan of Action and Milestones (POA&M) or equivalent document. This plan includes the rationale for the treatment choice, the expected residual risk after treatment, responsible parties, and timelines for implementation.
Step 4: Communication and Consultation
The risk treatment plan is communicated to all relevant stakeholders. This is not a one-way notification — it involves active consultation where stakeholders can ask questions, raise concerns, and suggest modifications. Open dialogue ensures that all perspectives are considered.
Step 5: Formal Concurrence
Each stakeholder reviews the proposed risk treatment plan and provides their formal concurrence (or non-concurrence). This is typically documented through:
• Signed concurrence letters or forms
• Documented meeting minutes where agreement was reached
• Electronic approval workflows in GRC tools
• Entries in the system's security authorization package
Step 6: Resolution of Non-Concurrence
If a stakeholder does not concur, the process must address their concerns. This may involve:
• Revising the risk treatment approach
• Providing additional justification or evidence
• Escalating the disagreement to a higher authority for resolution
• Documenting the dissenting opinion alongside the final decision
Step 7: Final Authorization Decision
Once concurrence is achieved (or non-concurrence is formally resolved), the authorization package — including evidence of stakeholder concurrence — is submitted to the Authorizing Official for the final authorization decision.
Step 8: Ongoing Review
Stakeholder concurrence is not a one-time event. As the risk landscape evolves, new risks emerge, and systems change, stakeholders must be re-engaged to concur on updated risk treatment strategies during continuous monitoring and reauthorization cycles.
Key Frameworks and Standards
Several authoritative sources guide stakeholder concurrence for risk treatment:
• NIST SP 800-37 Rev. 2 (Risk Management Framework) — Emphasizes stakeholder involvement throughout all RMF steps, particularly during the Authorize step where concurrence on residual risk is critical.
• NIST SP 800-39 (Managing Information Security Risk) — Describes the organizational risk management structure and the role of stakeholders at all tiers (organization, mission/business process, and information system).
• NIST SP 800-30 Rev. 1 (Guide for Conducting Risk Assessments) — Provides guidance on risk assessment that feeds into the risk treatment decision-making process.
• CNSSI 1253 — For national security systems, provides categorization and control selection guidance where stakeholder involvement is essential.
• OMB Circular A-130 — Requires federal agencies to implement risk-based approaches with stakeholder engagement.
Common Challenges in Achieving Stakeholder Concurrence
• Conflicting priorities: Business owners may prioritize availability while security teams prioritize confidentiality, leading to disagreements on appropriate risk treatments.
• Lack of risk literacy: Some stakeholders may not fully understand the technical aspects of risks, making informed concurrence difficult.
• Organizational silos: Poor communication between departments can impede the concurrence process.
• Time constraints: Pressure to meet authorization deadlines may lead to rushed or superficial concurrence.
• Incomplete documentation: Without clear, well-organized risk treatment documentation, stakeholders cannot make informed decisions.
Exam Tips: Answering Questions on Stakeholder Concurrence for Risk Treatment
Tip 1: Know Your Stakeholder Roles
Exam questions frequently test whether you understand who is involved in the concurrence process. Remember that the Authorizing Official makes the final risk acceptance decision, but they rely on concurrence from system owners, ISSOs, CISOs, and mission/business owners. Know the distinction between these roles and their specific responsibilities in the risk treatment process.
Tip 2: Understand the Four Risk Treatment Strategies
Be prepared to identify which risk treatment strategy is being described in a scenario. Questions may present a situation and ask which treatment is most appropriate. Remember: mitigation reduces risk, acceptance acknowledges it, avoidance eliminates it, and transfer shifts it.
Tip 3: Focus on Documentation Requirements
Many exam questions will test your knowledge of how concurrence is documented. Key artifacts include the POA&M, the Security Assessment Report (SAR), the System Security Plan (SSP), and the authorization decision document. Know which documents require stakeholder input and approval.
Tip 4: Remember That Non-Concurrence Must Be Addressed
If a question describes a scenario where a stakeholder disagrees with a risk treatment, the correct answer will almost always involve addressing the concern — not ignoring it, overriding it without documentation, or proceeding without resolution. Non-concurrence requires escalation, negotiation, or revision.
Tip 5: Think Organizationally, Not Just Technically
CGRC exam questions often test whether you can think beyond technical controls. Stakeholder concurrence is fundamentally about governance — ensuring that risk decisions are made collaboratively with input from diverse perspectives. If an answer choice focuses solely on technical solutions without stakeholder engagement, it is likely incorrect.
Tip 6: Recognize the Continuous Nature of Concurrence
Concurrence is not a one-and-done activity. Questions may test whether you understand that stakeholder concurrence must be revisited during continuous monitoring, when significant changes occur, or during reauthorization. The correct answer will reflect the ongoing nature of risk management.
Tip 7: Connect Concurrence to the RMF Steps
Stakeholder concurrence is most closely associated with the Authorize step of the RMF but has implications across all steps. Be prepared to identify where in the RMF lifecycle stakeholder input is required. For example, during the Select step, stakeholders may need to concur on control selections; during Assess, they review findings; and during Authorize, they formally concur on residual risk.
Tip 8: Watch for Keywords in Questions
Look for keywords such as concurrence, agreement, approval, acceptance, acknowledgment, residual risk, risk response, and stakeholder engagement. These signal that the question is testing your understanding of the concurrence process.
Tip 9: Prioritize Risk-Based Thinking
The CGRC exam rewards risk-based thinking. When faced with a question about stakeholder concurrence, consider which answer best reflects a balanced, risk-informed decision that considers mission needs, security requirements, and organizational risk tolerance.
Tip 10: Practice with Scenarios
Many CGRC questions are scenario-based. Practice reading scenarios carefully, identifying the stakeholders involved, determining the appropriate risk treatment, and selecting the answer that demonstrates proper governance and concurrence processes.
Summary
Stakeholder concurrence for risk treatment is a cornerstone of effective risk governance. It ensures that risk decisions are made transparently, collaboratively, and in alignment with organizational objectives. For the CGRC exam, understanding who participates in concurrence, what they concur on, how the process works, and why it matters will position you to answer questions on this topic with confidence. Remember that governance is about people and processes working together to make informed risk decisions — and stakeholder concurrence is the mechanism that makes this happen.
Unlock Premium Access
Certified in Governance, Risk and Compliance
- Access to ALL Certifications: Study for any certification on our platform with one subscription
- 2520 Superior-grade Certified in Governance, Risk and Compliance practice questions
- Unlimited practice tests across all certifications
- Detailed explanations for every question
- CGRC: 5 full exams plus all other certification exams
- 100% Satisfaction Guaranteed: Full refund if unsatisfied
- Risk-Free: 7-day free trial with all premium features!